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Purpose: To identify the genetic defect in two Pakistani families with autosomal recessive achromatopsia.
Methods: Two families (RP26 and RP44) were originally diagnosed with retinal dystrophy based upon their medical
history. To localize the causative genes in these families, homozygosity mapping was performed using Affymetrix 10K
single nucleotide polymorphism (SNP) arrays. Sequence analysis was used to find the mutations in candidate genes cyclic
nucleotide-gated channel alpha-3 (CNGA3; family RP26) and cyclic nucleotide-gated channel beta-3 (CNGB3; family
RP44). Control individuals were analyzed by allele-specific PCR for the CNGA3 mutation and BstXI restriction analysis
for the CNGB3 mutation. After genetic analysis, clinical diagnosis was re-evaluated by electroretinography and color
vision testing. During the course of this study, selected affected members of family RP26 were given pink glasses as
supportive therapy.
Results: Sequence analysis of the positional candidate genes identified a novel missense mutation in CNGA3 (c.822G>T;
p.R274S) in family RP26, and a novel CNGB3 frameshift mutation (c.1825delG; p.V609WfsX9) in family RP44. Clinical
re-evaluation after genetic analysis revealed that both families have segregating autosomal recessive achromatopsia.
Conclusions: Genetic analysis of two Pakistani families with retinal disease enabled the establishment of the correct
diagnosis of achromatopsia. Two novel mutations were identified in CNGA3 and CNGB3 that are both specifically
expressed in cone photoreceptors. Re-evaluation of the clinical status revealed that both families had achromatopsia. The
use of pink glasses in patients was helpful in reducing photophobia and enabled rod-mediated vision.
Achromatopsia (ACHM; OMIM 216900) is a congenital
autosomal recessive cone disorder with a prevalence of 1 in
30,000 individuals [1]. The clinical features include low
visual acuity, nystagmus, photophobia, severe color vision
defects, and no recordable or only residual cone function on
electroretinography (ERG) with normal rod functions.
Fundoscopy is usually normal, although macular pigmentary
changes and atrophy have been described in the literature
[2-5]. ACHM is characterized by progressive cone loss, which
has been described in a large proportion of patients in terms
of the worsening of the macular appearance and deterioration
of the central vision irrespective of the genetic cause [5,6]. It
has been reported that the use of red contact lenses or red tinted
glasses can alleviate photophobia in patients with ACHM or
cone dystrophy [7,8].
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To date, ACHM has been described as being caused by
mutations in four genes: cyclic nucleotide-gated channel
alpha-3 (CNGA3), cyclic nucleotide-gated channel beta-3
(CNGB3), guanine nucleotide-binding protein, alpha-
transducing activity polypeptide 2 (GNAT2), and
phosphodiesterase 6C (PDE6C) [9-14]. The proteins encoded
by these four genes are specifically expressed in cone
photoreceptor cells, where they have been shown to be
involved in the cone phototransduction cascade. CNGA3
encodes the α-subunit and CNGB3 the β-subunit of the cyclic
nucleotide-gated (CNG) channel that has a central function in
signal transduction of the visual pathway [15]. 25% of all
ACHM patients carry mutations in CNGA3, and 45%–50%
carry CNGB3 mutations, whereas only a few families have
been reported to have GNAT2 or PDE6C mutations [14-18].
Mutations in CNGA3,CNGB3, and PDE6C have also been
associated with cone dystrophy in a small proportion of
patients [10,14].
In the present study, we report two Pakistani families
(RP26 and RP44) which were initially classified as having
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retinal dystrophy, but after performing genetic analysis they
were reclassified as having ACHM.
METHODS
Initial diagnosis: Two families (RP26 and RP44) were
collected from different areas of Pakistan. Family RP26 was
collected from the Punjab province, while RP44 was collected
from the North West Frontier Province. After documenting
the initial clinical histories, both families were initially
diagnosed to suffer from retinal dystrophy.
Ethics declaration: This study conforms to the Helsinki
declaration and was approved by the Shifa College of
Medicine/Shifa International Hospital Ethics Committee/
Institutional Review Board (Islamabad, Pakistan). All patients
were informed in their local language of the purpose of the
study, and gave their informed written consent before they
were further analyzed.
Genetic analysis:
DNA isolation and marker analysis—For family RP26,
blood samples were collected from 16 individuals (four
affected and 12 healthy individuals) from a six generation
pedigree (Figure 1A). For family RP44, blood samples were
collected from eight individuals (two affected and six normal
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Figure 1. Pedigrees and genotyping results of Pakistani achromatopsia (ACHM) families RP26 and RP44. A: Pedigree with marker haplotypes
for cyclic nucleotide-gated channel alpha-3 (CNGA3) at 2q11.2 for family RP26. White circles represent healthy females, filled circles affected
females, white squares healthy males, and filled squares affected males. Deceased individuals are shown with a slanting line across the symbol.
Haplotypes were constructed for a 9.1-Mb interval on chromosome 2q11.2, encompassing the CNGA3 gene (indicated with an arrowhead).
B: Family RP44 and segregation of the c.1825delG mutation (M) in CNGB3 (+ represents the wild type alleles).
individuals) from a four-generation pedigree (Figure 1B).
DNA isolation was performed as described previously [19].
All the affected members of family RP26 (IV-1, V-2, V-3,
VI-2), and seven individuals of family RP44 (healthy
individuals III-2, IV-2, IV-4, IV-6, IV-7 and affected
individuals IV-1 and IV-3) were genotyped using the
Affymetrix 10K single nucleotide polymorphism (SNP) array
containing 10,204 SNPs (Affymetrix, Santa Clara, CA).
Multipoint parametric linkage analysis of the SNP array
data of both families was performed using the GeneHunter
program in the EasyLinkage software package (version 5.02)
[20]. Fine-mapping of the region on chromosome 2q11.2 with
the highest logarithm (base 10) of odds (LOD) score in family
RP26 was conducted using microsatellite markers that were
amplified by the polymerase chain reaction (PCR) under
standard conditions. Haplotypes were constructed based upon
the size of the alleles of the microsatellites. The positions of
the microsatellite markers were derived from the Marshfield
map. Two-point parametric LOD scores for the microsatellite
markers were calculated using the SuperLink program
(version 1.6) in the EasyLinkage software package [20].
Sequencing of candidate genes: The sequencing primers for
the candidate genes CNGA3 and CNGB3 have been described
before [5]. For family RP26, the seven coding exons of the
CNGA3 gene were sequenced in one affected individual (V-2)
along with a control sample, and for family RP44, all 18
coding exons of the CNGB3 gene were sequenced in
individual IV-1 as well as a control sample. The amplified
PCR products were separated on agarose gel and purified with
a Nucleospin DNA extraction kit (Nucleospin Extract II,
Macherey-Nagel GmbH and Co, Germany). Purified products
were directly sequenced using the corresponding primers and
dye-termination chemistry (BigDye Terminator, version 3 on
a 3730 or 2100 DNA analyzer; Applied Biosystems, Foster
City, CA).
Segregation analysis and panel screening: Segregation of the
CNGA3 mutation in family RP26, and analysis of the mutation
in 22 unrelated probands with autosomal recessive retinal
dystrophies and 150 ethnically-matched control individuals,
was performed via allele-specific PCR [21]. For this purpose,
three primers were designed; a forward wild type (5′-AAA
GGT GGG CAC AAA CTA CCC AGA AGT GAG G-3′),
forward mutant (5′-AAA GGT GGG CAC AAA CTA CCC
AGA AGT GAG T-3′) and a common reverse primer (5′-AAT
GGC AAA GTA GAT GCA GGC ATT CCA GTG G-3′).
DNA was amplified using 0.5 mM dNTPs, 1.5 mM MgCl2,
0.3 μM of each forward and reverse primer, and 2.5 U Taq
polymerase. The thermal cycling conditions were as follows:
initial denaturation at 95 °C for 5 min, followed by 35 cycles
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Figure 2. Sequence analysis and amino
acid conservation of the mutated cyclic
nucleotide-gated channel alpha-3
(CNGA3) amino acid residue in family
RP26. A: Sequence trace of part of exon
8 in a normal control individual (left
panel) and an affected individual (V-2;
right panel) showing the homozygous
mutant sequence c.822G>T (p.R274S).
B: Protein sequence alignment of
CNGA3 in different species. The
mutated arginine residue is highly
conserved. The conserved amino acids
between different species are shown in
black boxes, and the less conserved
amino acids are highlighted in light gray
or white boxes.
at 95 °C for 30 s, 60 °C for 30 s, and 72 °C for 30 s, with a
final extension cycle at 72 °C for 6 min.
Segregation analysis for the CNGB3 mutation in family
RP44 was performed by direct sequencing of exon 16.
Screening of 44 probands with retinal dystrophies for this
CNGB3 mutation was performed by amplification of exon 16
(357 bp) followed by BstXI digestion of the amplified
products. Wild-type alleles were digested into 183 bp and 174
bp fragments, whereas mutant alleles remained undigested.
Clinical re-evaluation: Due to the specific genetic defect that
was identified, the affected members of family RP26 were
clinically revisited and a detailed clinical examination was
performed to confirm the status of the disease in the family.
Fundoscopy and electroretinogram (ERG) data were obtained
for both families. Visual acuity tests were performed for the
affected individuals (IV-1, V-2, and VI-2) of family RP26,
and they were also subjected to color differentiation tests
using the standard Ishihara plates. Family RP44 could not be
revisited for the visual acuity test, but a detailed clinical
history was documented from the proband (IV-1) of the
family. The affected members of family RP26 were also given
pink glasses to use for the alleviation of photophobia.
RESULTS
Initial clinical results: Initially, both families (RP26 and
RP44) were diagnosed as having retinal dystrophy. This
diagnosis was based on their clinical history, because the
patients complained about vision loss and nystagmus.
Homozygosity mapping: In family RP26, whole-genome SNP
array analysis revealed a homozygous interval of 9.1 Mb at
2q11.2 between SNP rs718159 and rs1375002 in all the
affected members, with a multi-point LOD score of 3.81 at
theta 0. Confirmation and refinement of this region was
performed by analyzing microsatellite markers between
flanking SNPs rs718159 and rs1375002. As a result, the
critical region for the underlying defect was refined from the
initial 9.1 Mb to 7.2 Mb, flanked by markers rs718159 and
D2S2229 (Figure 1A). This region contains the CNGA3 gene,
which has previously been implicated in ACHM and cone
dystrophy [9]. In family RP44, homozygosity was observed
at nine different chromosomal regions in both affected
members (IV-1, IV-3), with a LOD score of 1.22 at theta 0,
whereas the unaffected individuals III-2, IV-2, IV-4, IV-6,
and IV-7 were heterozygous in these regions. The CNGB3
gene, which has also previously been shown to be involved in
ACHM and cone dystrophy, resides in one of these regions on
chromosome 8q21.3 [11].
Sequence analysis: Sequence analysis of all the coding exons
of the CNGA3 gene in the proband of family RP26 revealed a
novel change of nucleotide G>T at position 822 (c.822G>T)
in exon 8 in the affected family member V-2. This nucleotide
change results in the substitution of a serine residue for an
arginine residue (p.R274S; Figure 2A). The mutation
segregates with the disease in the family, and the mutation was
not detected in 22 unrelated probands with autosomal
recessive retinal dystrophies, or in 150 ethnically-matched
controls.
Sequencing of all the coding exons of the CNGB3 gene
in the proband of family RP44 resulted in the identification of
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Figure 3. Sequence analysis of cyclic nucleotide-gated channel
beta-3 (CNGB3) in family RP44. Sequence trace of part of exon 16
in a normal control individual (upper panel), an affected individual
carrying a homozygous c.1825delG mutation (middle panel), and a
heterozygous carrier of the mutation (lower panel).
a novel mutation, a one nucleotide deletion at position 1825
in exon 16 of the gene c.1825delG; Figure 3A), which results
in a frameshift and premature termination of the protein
(p.V609WfsX9). Segregation analysis in the family revealed
that the two affected individuals, IV-1 and IV-3, are
homozygous for the mutation, while four healthy persons
(III-2, IV-2, IV-4, IV-7) are heterozygous carriers, and two
healthy persons (IV-5, IV-6) are homozygous for the wild type
allele (Figure 1B and Figure 3A). The c.1825delG mutation
was not identified in 44 probands with retinal dystrophies.
Clinical re-evaluation: As it has previously been reported that
mutations in CNGA3 and CNGB3 are associated with cone
dysfunction [9-11], the clinical status of the affected
individuals from both families was re-evaluated. The affected
individuals of family RP26 (IV-1 and VI-2), who were aged
35 and 11 years, respectively, at the time of fundoscopy,
showed a normal macular region. However, one affected
individual from each family (RP26_V-2 [age 14 years] and
RP44_IV-1 [age 19 years]) showed the beginning of a Bull’s
eye maculopathy (Figure 4), and revealed some residual cone
responses on the photopic ERG on the 30 Hz flicker
stimulation (Figure 5), showing that the disease is progressive
in these patients.
The affected individuals from family RP26 had
congenital nystagmus, photophobia and were color blind. In
addition, the affected individuals (IV-1, V-2, and VI-2) had
low visual acuity of 20/200, 20/400, and 20/200, respectively.
Members of family RP44 could not be revisited for the visual
acuity test because they live in a very remote rural area. In this
family, a detailed telephone interview with both affected
members IV-1 and IV-3 revealed that they also had congenital
nystagmus. In addition, they had photophobia along with low
visual acuity and were found to be color blind, thereby
confirming the molecular diagnosis of ACHM.
In previous studies, affected individuals with cone-
dysfunction have been treated with red colored-tinted glasses
or red contact lenses to reduce photophobia [7,8]. To
determine whether this would also help in family RP26, the
affected individuals (IV-1, V-2) were given pink glasses to
wear. After continuous use of the glasses for two months, a
significant decrease in photophobia was observed in these
patients.
DISCUSSION
In this study, we identified two Pakistani families with
autosomal recessive ACHM. All affected individuals had an
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Figure 4. Fundus photographs of
affected individuals from families RP26
and RP44. Fundus photographs of
affected individual V-2 of family RP26
A, B) and IV-1 of family RP44 (C, D).
Patient RP26_V-2 and patient
RP44_IV-1 show the beginning signs of
a Bull’s eye maculopathy (indicated
with an arrowhead).
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Figure 5. Electroretinogram (ERG) of
the normal and affected members of the
families RP26 and RP44. The photopic
ERGs (A, C) of the unaffected
individuals (RP26_IV:2, RP44_IV:6) of
families RP26 and RP44 indicated
normal cone responses. In comparison,
the affected individuals (RP26_V:2,
RP44_IV:1) of both families had
residual cone responses (B, D).
early onset of nystagmus, photophobia and low visual acuity
with color blindness. In these two families, novel mutations
were identified in CNGA3 (c.822G>T, p.R274S) and CNGB3
(c.1825delG, p.V609WfsX9).
There are six cyclic nucleotide gated (CNG) channels
present in mammals, and these are divided in two subfamilies,
the A subunits (CNGA1–4) and the B subunits (CNGB1 and
CNGB3). The CNGA3 and CNGB3 channels play a critical
role in cone-mediated vision, which is required for central and
color vision, as well as visual acuity. CNGA3 and CNGB3
encode the cone CNG channel subunits [22] that are able to
form heterotetramers [23], although CNGA3 subunits may
also form homotetramers [24]. Mutations in these two genes
have been shown to result in different forms of ACHM and
cone dystrophy [23].
In CNGA3, the p.R274S mutation is located in a
conserved region (Figure 2B), which is part of the fourth
transmembrane helix (S4) [17]. The arginine residue at this
position is conserved among the CNG alpha subunits of rods
(CNGA1) and olfactory neurons (CNGA2), Shaker K+
channels and HCN channels [25]. Mutations in the S4 domain
have been shown to cause failure in cellular channel
processing. Mutant channel proteins are not glycosylated, and
do not reach the surface plasma membrane; they remain
trapped in the endoplasmic reticulum, and are most likely
misfolded [25].
The c.1825delG mutation in exon 16 of CNGB3 should
in theory give rise to nonsense-mediated decay of the mutant
RNA, and can, therefore, be considered a loss-of-function
mutation. In case there is residual CNGB3 mRNA, the
predicted truncated protein (p.V609WfsX9) lacks the
conserved cyclic nucleotide-monophosphate (cNMP)
domain. The cNMP domain is the binding site for cyclic
nucleotides, and is involved in the cyclic nucleotide mediated
activation of the protein. It is hypothesized that both putative
effects of this variant will lead to the loss-of-function of
CNGB3.
Identification of causative mutations aided in the correct
diagnosis of ACHM in these two Pakistani families, which
had previously been diagnosed to suffer from retinal
dystrophy. After the correct re-diagnosis of the disease, the
use of pink glasses reduced the photophobia to some extent in
the affected individuals of family RP26. Due to the use of
these dark colored pink glasses, the light exposure was
reduced, resulting in increased scotopic vision that helped the
patients to see objects at a distance, even during the day time.
In this study, we report the first genetic screening and use of
dark glasses as supportive therapy for ACHM in Pakistan, a
disease that is often misdiagnosed.
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